文献速递运动医学关节外科

157例关节镜下同种异体半月板移植骨固定平均7年生存率及预后因素分析

Survivorship of 157 Arthroscopic Meniscal Allograft Transplants Using Bone Fixation at a Mean of 7 Years and Prognostic Factors Analysis.
PubMed 文献 · Am J Sports Med · 2024-01-01

单中心连续185膝前瞻性收集、157膝纳入分析,平均随访7±3.5年,80.9%膝无临床、解剖及主观失败;合并骨软骨同种异体移植和ICRS 3或4级软骨损伤增加临床与解剖失败风险,但患者报告结局评分均显著改善。

要点

  • 平均随访7年,80.9%膝无临床、解剖及主观失败,KOOS与IKDC较术前显著改善。
  • 合并骨软骨同种异体移植预测临床失败(HR 4.55)与解剖失败(HR 3.05)。
  • ICRS 3或4级软骨损伤增加临床失败(HR 3.41)与解剖失败(HR 3.04)风险。

核心结论

  • 同种异体半月板移植在平均7年随访时显示良好至优秀的临床结果,低ICRS损伤级别与更高的临床和解剖生存率相关。
  • 合并骨软骨同种异体移植的患者临床和解剖失败风险更高,但患者报告结局评分仍显著改善。
  • 作者认为同种异体半月板移植无论单独应用还是合并至少1项复杂手术均具有持久有益效果。

研究设计与样本

  • 病例对照研究,证据等级3级;单机构连续185膝前瞻性收集数据并筛选纳入,最终157膝符合纳入标准,最低随访时间2年。

主要发现

  • 平均随访7±3.5年,127膝(80.9%)无临床、解剖及主观失败;14膝(8.9%)发生临床失败,26膝(16.6%)发生解剖失败,13例(8.3%)患者主观失败(Lysholm评分≤65)。
  • 合并骨软骨同种异体移植是临床失败(HR 4.55;95%CI 1.46-14.17;P=.009)和解剖失败(HR 3.05;95%CI 1.34-6.92;P=.008)的预测因素。
  • 原发间室ICRS 3或4级软骨损伤增加临床失败(HR 3.41;95%CI 1.05-11.01;P=.04)和解剖失败(HR 3.04;95%CI 1.31-7.11;P=.01)风险。
  • 术前高级别软骨损伤(HR 10.67;95%CI 1.037-109.768;P=.046)、患者年龄>25岁(HR 5.44;95%CI 0.120-246.070;P=.384)和BMI>30(HR 2.24;95%CI 0.748-6.705;P=.149)与主观失败相关。
  • 末次随访时KOOS(含各亚项)和IKDC等所有患者报告结局测量指标较术前显著改善(P<.005)。

关键数值与推荐

  • 临床失败定义为因移植物失败行翻修手术或转为全膝关节置换术。
  • 解剖失败定义为撕裂覆盖>20%同种异体移植物、任何周边撕裂以及周边固定不稳定导致移植物脱位。
  • 主观失败定义为Lysholm评分≤65。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Meniscal allograft transplantation (MAT) is an accepted and effective treatment option in the context of unsalvageable menisci, particularly in young and active patients. It has been shown to reduce pain and improve knee function in previously symptomatic patients. However, there is still limited knowledge about the long-term survival rates of allografts, the durability of clinical results, and the influence of patient-specific parameters, such as leg alignment, tibial slope, and preoperative International Cartilage Regeneration & Joint Preservation Society (ICRS) grade. PURPOSE: To determine (1) the long-term clinical success rate after MAT with bony fixation in a large, single-center cohort of consecutive patients, and (2) if patient-specific and procedural variables influence the clinical, anatomic, and subjective outcomes and risk of failure. STUDY DESIGN: Case-control study; Level of evidence, 3. METHODS: Data on 185 consecutive knees undergoing MAT in a single institution were prospectively collected and screened for inclusion in this study. The minimum follow-up time was 2 years. Radiographic variables (ICRS grade and Kellgren-Lawrence grade) were assessed preoperatively and at follow-up. Subjective patient-reported outcome measures (PROMs) (Lysholm score, Knee injury and Osteoarthritis Outcome Score [KOOS] including subscores, International Knee Documentation Committee [IKDC] score, and visual analog scale [VAS] score) were collected preoperatively and at follow-up. Clinical failure was defined as revision surgery due to graft failure or conversion to total knee arthroplasty. Anatomic failure was considered a tear covering >20% of the allograft, any peripheral tear, and unstable peripheral fixation leading to dislocation of the graft. Subjective failure was defined as Lysholm score ≤65. Preoperative tibial slope and leg alignment were assessed. Survival analyses were performed using the Kaplan-Meier estimate. Univariate and multivariate analyses were performed to determine risk factors for clinical and anatomic failure. RESULTS: A total of 157 knees met inclusion criteria. After a mean follow-up time of 7 ± 3.5 years, 127 (80.9%) knees were free of clinical, anatomic, and subjective failure. Fourteen (8.9%) knees experienced clinical failure, 26 (16.6%) knees were identified as having experienced anatomic failure, and 13 (8.3%) patients experienced subjective failure with a reported Lysholm score of ≤65 at a mean follow-up of 7 years. Concurrent osteochondral allograft transplantation was identified as a predictor of both clinical (hazard ratio [HR], 4.55; 95% CI, 1.46-14.17; P = .009) and anatomic (HR, 3.05; 95% CI, 1.34-6.92; P = .008) failure. Cartilage damage of ICRS grade 3 or 4 of the index compartment conveyed an increased risk for clinical (HR, 3.41; 95% CI, 1.05-11.01; P = .04) and anatomic (HR, 3.04; 95% CI, 1.31-7.11; P = .01) failure. High-grade cartilage damage preoperatively (HR, 10.67; 95% CI, 1.037-109.768; P = .046), patient age >25 years (HR, 5.44; 95% CI, 0.120-246.070; P = .384), and a body mass index >30 (HR, 2.24; 95% CI, 0.748-6.705; P = .149) were associated with subjective failure. PROMs including KOOS and IKDC were significantly improved at final follow-up compared with preoperative scores across all measurements (P < .005). CONCLUSION: MAT showed good to excellent clinical results at a mean follow-up of 7 years. Low ICRS lesion grade was associated with a higher clinical and anatomic survival rate. Patients with concurrent OCA transplantation are at a higher risk of clinical and anatomic failure, but still report significantly improved PROMs. These results suggest that MAT has a lasting beneficial effect both in isolation and in complex cases with ≥1 concurrent procedures.

来源:Am J Sports Med,查看原文。版权归原作者所有。

引用

  1. Husen M, Poudel K, Wang A, et al. Survivorship of 157 Arthroscopic Meniscal Allograft Transplants Using Bone Fixation at a Mean of 7 Years and Prognostic Factors Analysis. Am J Sports Med. 2024. PMID: 38164687. doi:10.1177/03635465231212667

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。